Sheets Smith Investment Management Cardiol Therapeutics Inc. Transaction History
Sheets Smith Investment Management
- $139 Million
- Q3 2025
A detailed history of Sheets Smith Investment Management transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Sheets Smith Investment Management holds 142,097 shares of CRDL stock, worth $147,780. This represents 0.11% of its overall portfolio holdings.
Number of Shares
142,097Holding current value
$147,780% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
43Shares Held
6.7MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X03.27MShares$3.4 Million2.06% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$891,6830.22% of portfolio
-
Lion Street Advisors, LLC340KShares$353,6260.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$304,7780.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$294,8101.46% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $64.4M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...